Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 13, Issue 5, pp. 1142-1154
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 12, 2013
- Revision received November 24, 2013
- Accepted November 25, 2013
- Published first January 16, 2014.
Article Versions
- Previous version (January 16, 2014 - 14:31).
- Previous version (April 18, 2014 - 06:57).
- You are viewing the most recent version of this article.
Copyright & Usage
©2014 American Association for Cancer Research.
Author Information
- Warren Fiskus1,
- Sunil Sharma2,
- Jun Qi3,
- John A. Valenta1,
- Leasha J. Schaub1,
- Bhavin Shah1,
- Karissa Peth1,
- Bryce P. Portier1,
- Melissa Rodriguez1,
- Santhana G.T. Devaraj1,
- Ming Zhan1,
- Jianting Sheng1,
- Swaminathan P. Iyer1,
- James E. Bradner3, and
- Kapil N. Bhalla1
- Authors' Affiliations: 1Houston Methodist Research Institute, Houston, Texas; 2Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 3Dana-Farber Cancer Institute, Boston, Massachusetts
- Corresponding Author:
Kapil N. Bhalla, Houston Methodist Research Institute, 6670 Bertner Ave., R9–113, Houston, TX 77030. Phone: 713-441-9113; Fax: 713-441-5349; E-mail: knbhalla{at}tmhs.org
May 2014
Volume 13, Issue 5
Volume 13, Issue 5
Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
Jump to section
Advertisement